ZVR 300 (Zidovudine 300 mg)

Pill imprint ZVR 300 has been identified as Zidovudine 300 mg.

Zidovudine is used in the treatment of reduction of perinatal transmission of hiv; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ZVR 300

Zidovudine
Imprint:
ZVR
300
Strength:
300 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cipla Ltd.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)